We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
42 hedge funds and large institutions have $34.2M invested in Arcturus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
105% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $555K
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
8.44% more ownership
Funds ownership: 0% → 8.44% (+8.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 43 → 42 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
21% less capital invested
Capital invested by funds: $43M → $34.2M (-$8.85M)
Holders
42
Holders Change
-1
Holders Change %
-2.33%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
14
Reduced
12
Closed
7
Calls
$1.14M
Puts
$555K
Net Calls
+$584K
Net Calls Change
-$827K
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$1.09M |
| 2 |
RA
Royce & Associates
New York
|
+$1.08M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$555K |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$541K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$305K |
